Examples of Analytical Method Implementation
Recommendation

Thursday, 29 October 2026 9 .00 - 17.15 h
AI/ML-based Methods for Optimizing Pharmaceutical Research Processes
Following the recently introduced new Ph. Eur. chapter 5.26 Implementation of pharmacopoeial procedures (Ph. Eur. 11.0), the EDQM published some examples. The intention is to provide users with practical guidance on how critical factors potentially affecting the Analytical Procedure Performance Characteristics (APPCs) can be identified. However, it is emphasized, that the pre-requisite for the implementation of any analytical procedure is a suitable quality system, which ensures that the requirements set for personnel, premises, and equipment are fulfilled.
Examples for Critical Factor Assessment
The following six examples are provided for the assessment of critical factors associated with the analytical procedure under actual conditions:
- Pharmaceutical ingredient (Mannitol) / Identification by infrared absorption spectrophotometry
- Drug product (Deferiprone tablets) / Related substances test by LC-UV
- Active substance (Benzylpenicillin potassium) / Assay by LC-UV
- Infliximab concentrated solution / Cell-based assay procedures
- Drug Product (Deferiprone oral solution) / Microbial enumeration test
- Active substance (Deferiprone) / Sulfated ash
More information is available in the Examples of implementation of pharmacopoeial procedures according to Chapter 5.26 "Implementation of pharmacopoeial procedures” published in Pharmeuropa Online under Technical Information.
Related GMP News
03.09.2026USP Article: Supporting the Detection of Asbestos in Pharmaceutical Talc
02.09.2026USP Publishes Comments Received on Chapter <320>
26.08.2026New USP Requirements for Asbestos Testing in Pharmaceutical Talc
19.08.2026FDA Warning Letter: Averaging Data to Override OOS Findings
12.08.2026ECA's Analytical Control Group Publishes Detailed Report on OOS Survey
12.08.2026BP Publishes Key Insights on Limits in Chromatographic Tests


